Robert Abel

1.5k total citations
40 papers, 1.1k citations indexed

About

Robert Abel is a scholar working on Ophthalmology, Surgery and Pharmacology. According to data from OpenAlex, Robert Abel has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 10 papers in Surgery and 8 papers in Pharmacology. Recurrent topics in Robert Abel's work include Intraocular Surgery and Lenses (10 papers), Lipoproteins and Cardiovascular Health (8 papers) and Ocular Infections and Treatments (7 papers). Robert Abel is often cited by papers focused on Intraocular Surgery and Lenses (10 papers), Lipoproteins and Cardiovascular Health (8 papers) and Ocular Infections and Treatments (7 papers). Robert Abel collaborates with scholars based in United States, New Zealand and China. Robert Abel's co-authors include R. Ross, Sue E. Leurgans, Perry S. Binder, Herbert E. Kaufman, Allen J. Sedman, Ralph H. Stern, Frank M. Polack, R. H. Stern, Lloyd R. Whitfield and RL Nagel and has published in prestigious journals such as Blood, Neurology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Robert Abel

39 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Abel United States 18 227 223 150 129 118 40 1.1k
Noboru Hamada Japan 24 107 0.5× 40 0.2× 123 0.8× 151 1.2× 19 0.2× 114 2.2k
Alain Munafo Switzerland 28 61 0.3× 35 0.2× 221 1.5× 51 0.4× 71 0.6× 63 1.9k
Johannes Lotz Germany 25 224 1.0× 17 0.1× 206 1.4× 195 1.5× 125 1.1× 70 1.6k
Ellen M. McDonagh United States 22 141 0.6× 31 0.1× 52 0.3× 107 0.8× 72 0.6× 35 2.9k
Xiaoyan Li China 17 76 0.3× 163 0.7× 139 0.9× 47 0.4× 22 0.2× 59 1.2k
QiPing Feng United States 22 452 2.0× 10 0.0× 46 0.3× 64 0.5× 25 0.2× 78 1.8k
John A. Farmer United States 31 2.2k 9.6× 61 0.3× 307 2.0× 185 1.4× 120 1.0× 105 3.8k
Óscar Garnica Spain 19 185 0.8× 128 0.6× 70 0.5× 76 0.6× 24 0.2× 91 1.2k
Naomi Gronich Israel 23 150 0.7× 19 0.1× 78 0.5× 48 0.4× 54 0.5× 50 1.6k
Christine Garnett United States 27 66 0.3× 19 0.1× 95 0.6× 68 0.5× 154 1.3× 71 2.6k

Countries citing papers authored by Robert Abel

Since Specialization
Citations

This map shows the geographic impact of Robert Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Abel more than expected).

Fields of papers citing papers by Robert Abel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Abel. The network helps show where Robert Abel may publish in the future.

Co-authorship network of co-authors of Robert Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Abel. A scholar is included among the top collaborators of Robert Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Abel. Robert Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Whitfield, Lloyd R., et al.. (2010). Effect of Gemfibrozil and Fenofibrate on the Pharmacokinetics of Atorvastatin. The Journal of Clinical Pharmacology. 51(3). 378–388. 42 indexed citations
2.
Bradley, Catherine S., David D. Rahn, Ingrid Nygaard, et al.. (2009). The questionnaire for urinary incontinence diagnosis (QUID): Validity and responsiveness to change in women undergoing non‐surgical therapies for treatment of stress predominant urinary incontinence. Neurourology and Urodynamics. 29(5). 727–734. 95 indexed citations
3.
Whitfield, Lloyd R., R. H. Stern, Allen J. Sedman, Robert Abel, & Donald M. Gibson. (2000). Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase. European Journal of Drug Metabolism and Pharmacokinetics. 25(2). 97–101. 26 indexed citations
4.
Boyd, Rebecca A., Dietrich Türck, Robert Abel, Allen J. Sedman, & Howard N. Bockbrader. (1999). Effects of Age and Gender on Single‐Dose Pharmacokinetics of Gabapentin. Epilepsia. 40(4). 474–479. 70 indexed citations
5.
Bullen, William W., Chetan Lathia, Robert Abel, & Roger N. Hayes. (1998). Validated HPLC/MS/MS assay for CI-1011 in rat plasma and a comparison with an HPLC/UV assay. Journal of Pharmaceutical and Biomedical Analysis. 17(8). 1399–1413. 2 indexed citations
6.
Koup, Jeffrey R., et al.. (1998). Effect of Age, Gender, and Race on Steady State Procainamide Pharmacokinetics After Administration of Procanbid Sustained-Release Tablets. Therapeutic Drug Monitoring. 20(1). 73–77. 3 indexed citations
7.
Loi, Cho‐Ming, Christine Alvey, Edward J. Randinitis, et al.. (1997). Meta‐Analysis of Steady‐State Pharmacokinetics of Troglitazone and Its Metabolites. The Journal of Clinical Pharmacology. 37(11). 1038–1047. 22 indexed citations
8.
Stern, Ralph H. & Robert Abel. (1997). Rate of Low‐Density Lipoprotein Cholesterol and Apolipoprotein B Changes on Initiation and Discontinuation of Atorvastatin Treatment. The Journal of Clinical Pharmacology. 37(4). 291–296. 6 indexed citations
9.
Stern, Ralph H., et al.. (1997). Atorvastatin Does Not Alter the Anticoagulant Activity of Warfarin. The Journal of Clinical Pharmacology. 37(11). 1062–1064. 35 indexed citations
10.
Stern, R. H., et al.. (1997). Renal Dysfunction Does Not Alter the Pharmacokinetics or LDL‐Cholesterol Reduction of Atorvastatin. The Journal of Clinical Pharmacology. 37(9). 816–819. 54 indexed citations
11.
Boyd, Rebecca A., Bingbing Yang, Robert Abel, et al.. (1996). Pharmacokinetics of a 7‐Day 17β‐Estradiol Transdermal Delivery System: Effect of Application Site and Repeated Applications on Serum Concentrations of Estradiol and Estrone. The Journal of Clinical Pharmacology. 36(11). 998–1005. 1 indexed citations
12.
13.
Nagel, RL, Elliott Vichinsky, M. A. Shah, et al.. (1993). F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood. 81(1). 9–14. 62 indexed citations
14.
Abel, Robert, et al.. (1991). Cornea Transplant Statistics in the United States. Journal of Refractive Surgery. 7(6). 467–468. 6 indexed citations
15.
Abel, Robert. (1987). Development of an Artificial Cornea. Cornea. 6(1). 56–56. 1 indexed citations
16.
Abel, Robert, et al.. (1976). Subconjunctival Gentamicin Prophylaxis Against Postoperative Endophthalmitis in the Rabbit. Ophthalmic surgery, lasers & imaging retina. 7(4). 59–66. 5 indexed citations
17.
Binder, Perry S., et al.. (1976). Aspirin and the intraocular pressure rise following aphakic penetrating keratoplasty: a negative report.. PubMed. 8(5). 611–4. 1 indexed citations
18.
Binder, Perry S., Robert Abel, Frank M. Polack, & Herbert E. Kaufman. (1975). Keratoplasty Wound Separations. American Journal of Ophthalmology. 80(1). 109–115. 77 indexed citations
19.
Binder, Perry S., Robert Abel, & Herbert E. Kaufman. (1975). Cyclocryotherapy for Glaucoma After Penetrating Keratoplasty. American Journal of Ophthalmology. 79(3). 489–492. 45 indexed citations
20.
Abel, Robert & John Craig. (1963). An intracardiac malignant tumour.. PubMed. 88. 667–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noboru Hamada Breakdown of academic impact, for papers by Alain Munafo Breakdown of academic impact, for papers by Johannes Lotz Breakdown of academic impact, for papers by Ellen M. McDonagh Breakdown of academic impact, for papers by Xiaoyan Li Breakdown of academic impact, for papers by QiPing Feng Breakdown of academic impact, for papers by John A. Farmer Breakdown of academic impact, for papers by Óscar Garnica Breakdown of academic impact, for papers by Naomi Gronich Breakdown of academic impact, for papers by Christine Garnett
Rankless by CCL
2026